Cochrane · systematic review · CD013854
Patient education interventions for the management of inflammatory bowel disease
Gordon, M, Sinopoulou, V, Ibrahim, U, et al. · Cochrane Database of Systematic Reviews · 2023 · Cochrane Library
GutAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
12
current version
GRADE rated
8
No studies
4
Included studies
NR
No studies 4 · 33.3%Ungraded 0 · 0%Very low 5 · 41.7%Low 0 · 0%Moderate 3 · 25%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Patient education and standard care compared to standard care for the management of inflammatory bowel disease
Population: people with inflammatory bowel disease
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Disease activity (3‐12 months) Patient education and standard care vs standard care | no estimate extracted | 2 studies · 479 participants | Moderate Downgraded: risk of bias, imprecision |
Flare‐ups or relapse (mean number during study period, start‐12 months) (continuous outcome) Patient education and standard care vs standard care | no estimate extracted | 2 studies · 1022 participants | Moderate Downgraded: risk of bias, imprecision |
Flare‐ups or relapse (4‐12 months) (dichotomous outcome) Patient education and standard care vs standard care | RR 0.94 [0.41, 2.18] | 3 studies · 307 participants | Very low Downgraded: risk of bias, imprecision |
Quality of life (2 weeks‐12 months) Patient education and standard care vs standard care | no estimate extracted | 6 studies · 1364 participants | Moderate Downgraded: risk of bias, imprecision |
Web‐based patient education versus other delivery of patient education for the management of inflammatory bowel disease
Population: people with inflammatory bowel disease
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Disease activity (8 weeks) Web‐based patient education vs other delivery of patient education | no estimate extracted | 1 study · 32 participants | Very low Downgraded: risk of bias, imprecision |
Flare‐ups or relapse (continuous) Web‐based patient education vs other delivery of patient education | no estimate extracted | NR | No studies |
Flare‐ups or relapse (dichotomous) Web‐based patient education vs other delivery of patient education | no estimate extracted | NR | No studies |
Quality of life, IBDQ (32 minimum score to 224 maximum score; high score = better quality of life) (8 weeks) Web‐based patient education vs other delivery of patient education | no estimate extracted | 1 study · 58 participants | Very low Downgraded: risk of bias, imprecision |
Weekly educational texts messages versus once every other week educational text messages for the management of inflammatory bowel disease
Population: people with inflammatory bowel disease
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Disease activity (12 months) Weekly educational texts messages vs once every other week educational text messages | no estimate extracted | 1 study · 131 participants | Very low Downgraded: risk of bias, imprecision |
Flare‐ups or relapse (continuous) Weekly educational texts messages vs once every other week educational text messages | no estimate extracted | NR | No studies |
Flare‐ups or relapse (dichotomous) Weekly educational texts messages vs once every other week educational text messages | no estimate extracted | NR | No studies |
Quality of life, IBDQ (32 minimum score ‐ 224 maximum score; high score = better quality of life) (12 months) Weekly educational texts messages vs once every other week educational text messages | no estimate extracted | 1 study · 193 participants | Very low Downgraded: risk of bias, imprecision |